Cooper; Anthony William James
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cooper; Anthony William James.The latest application filed is for "ether linked triazoles as nrf2 activators".
Company Profile
9.22.26
- Cooper; Anthony William James - Stevenage GB
- Cooper; Anthony William James - Hertfordshire GB
Patent Activity
| Patent | Date |
|---|---|
| Ether Linked Triazoles As Nrf2 Activators App 20220089590 - Cooper; Anthony William James ; et al. | 2022-03-24 |
| Bisaryl amides as NRF2 activators Grant 11,078,216 - Callahan , et al. August 3, 2 | 2021-08-03 |
| Ether linked triazoles as NRF2 activators Grant 11,059,816 - Cooper , et al. July 13, 2 | 2021-07-13 |
| Pyridinone dicarboxamide for use as bromodomain inhibitors Grant 10,927,080 - Atkinson , et al. February 23, 2 | 2021-02-23 |
| Chemical compounds Grant 10,793,559 - Anderson , et al. October 6, 2 | 2020-10-06 |
| Chemical Compounds App 20200071311 - ANDERSON; Niall Andrew ; et al. | 2020-03-05 |
| Ether Linked Triazoles As Nrf2 Activators App 20200071317 - COOPER; Anthony William James ; et al. | 2020-03-05 |
| Pyridinone Dicarboxamide For Use As Bromodomain Inhibitors App 20190359572 - ATKINSON; Stephen John ; et al. | 2019-11-28 |
| Bisaryl Amides As Nrf2 Activators App 20190330238 - CALLAHAN; James Francis ; et al. | 2019-10-31 |
| Chemical compounds Grant 10,457,674 - Anderson , et al. Oc | 2019-10-29 |
| Pyridinone dicarboxamide for use as bromodomain inhibitors Grant 10,428,026 - Atkinson , et al. October 1, 2 | 2019-10-01 |
| Chemical Compounds App 20190040051 - ANDERSON; Niall Andrew ; et al. | 2019-02-07 |
| Pyridinone Dicarboxamide For Use As Bromodomain Inhibitors App 20180258044 - ATKINSON; Stephen John ; et al. | 2018-09-13 |
| Pyrazole compounds acting against allergic, immune and inflammatory conditions Grant 9,156,791 - Cooper , et al. October 13, 2 | 2015-10-13 |
| Pyrazole compounds acting against allergic, inflammatory and immune disorders Grant 9,149,462 - Cooper , et al. October 6, 2 | 2015-10-06 |
| Pyrazole Compounds Acting Against Allergic, Inflammatory And Immune Disorders App 20130217658 - Cooper; Anthony William James ; et al. | 2013-08-22 |
| Pyrazole Compounds Acting Against Allergic, Immune and Inflammatory Conditions App 20130203705 - Cooper; Anthony William James ; et al. | 2013-08-08 |
| N-pyrazolyl carboxamides as CRAC channel inhibitors Grant 8,399,436 - Allen , et al. March 19, 2 | 2013-03-19 |
| 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase Grant 8,354,416 - Callahan , et al. January 15, 2 | 2013-01-15 |
| Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions App 20120277279 - BARNETT; Heather Anne ; et al. | 2012-11-01 |
| Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditions Grant 8,247,377 - Barnett , et al. August 21, 2 | 2012-08-21 |
| Compounds Grant 8,207,176 - Callahan , et al. June 26, 2 | 2012-06-26 |
| Compounds Grant 8,178,573 - Biggadike , et al. May 15, 2 | 2012-05-15 |
| N-pyrazolyl Carboxamides As Crac Channel Inihibitors App 20120053150 - Allen; David George ; et al. | 2012-03-01 |
| Pyrazole And Triazole Carboxamides As Crac Chann El Inhibitors App 20120035237 - Coe; Diane Mary ; et al. | 2012-02-09 |
| Compounds Grant 7,947,727 - Biggadike , et al. May 24, 2 | 2011-05-24 |
| Compounds Grant 7,943,651 - Biggadike , et al. May 17, 2 | 2011-05-17 |
| Novel Compounds App 20100234441 - Barnett; Heather Anne ; et al. | 2010-09-16 |
| Novel Compounds App 20100120883 - Biggadike; Keith ; et al. | 2010-05-13 |
| Compounds Grant 7,678,801 - Callahan , et al. March 16, 2 | 2010-03-16 |
| Pyrazole Derivatives As Non-steroidal Glucocorticoid Receptor Ligands App 20100035926 - Campbell; Ian Baxter ; et al. | 2010-02-11 |
| Novel Compounds App 20100016331 - Biggadike; Keith ; et al. | 2010-01-21 |
| Novel Compounds App 20090156597 - Callahan; James F. ; et al. | 2009-06-18 |
| Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors Grant 7,528,148 - Allen , et al. May 5, 2 | 2009-05-05 |
| Novel Compounds App 20090111866 - Biggadike; Keith ; et al. | 2009-04-30 |
| Novel Compounds App 20090069318 - Callahan; James Francis ; et al. | 2009-03-12 |
| Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors Grant 7,465,743 - Coe , et al. December 16, 2 | 2008-12-16 |
| Muscarinic Acetylcholine Receptor Antagonists App 20080287487 - Cooper; Anthony William James ; et al. | 2008-11-20 |
| Muscarinic Acetylcholine Receptor Antagonists App 20080249127 - Laine; Dramane I. ; et al. | 2008-10-09 |
| Novel Compounds App 20070265326 - BIGGADIKE; Keith ; et al. | 2007-11-15 |
| Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors App 20070167485 - Coe; Diane Mary ; et al. | 2007-07-19 |
| Novel compounds App 20060235029 - Callahan; James F. ; et al. | 2006-10-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 